Article Text

Download PDFPDF
Randomised controlled trial
LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patients

Statistics from Altmetric.com

Footnotes

  • Competing interests MC is a consultant and a member of the Speaker Bureau at Novartis.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.